A QSAR study on 5-HT7 receptor antagonists: Derivatives of (phenylpiperazinyl-alkyl) oxindole

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn , Issue 1, 2009, Pages 227-239

  Sharma, Brij Kishore ^a   Singh, Prithvi ^a   Sarbhai, Kirti ^a  

^a SK Government College   (India)

Author keywords

5 HT7 receptor antagonists; Binding affinity; Fujita Ban and Hansch analysis; QSAR

Indexed keywords

(PHENYLPIPERAZINYLALKYL)OXINDOLE DERIVATIVE; OXINDOLE; SEROTONIN 7 RECEPTOR; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG;

ARTICLE; CHO CELL; DRUG RECEPTOR BINDING; DRUG STRUCTURE; FUJITA BAN ANALYSIS; MULTIPLE REGRESSION; NONPARAMETRIC TEST; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 77953412436     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Hoyer D, Hannon JP, Martin GR Molecular, Pharmacological and Functional Diversity of 5-HT receptors. Pharmacol Biochem Behav 2002;71:533-554.
2. 7. J Med Chem 2003;46:2795-2810.
3. Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ Jr, Shen Y, et al. Binding of Typical and Atypical Antipsychotic Agents to 5-Hydroxytryptamine-6 and 5-Hydroxytryptamine-7 Receptors. J Pharm Exp Ther 1994;268:1403-1410.
4. 7 Receptor Regulation in the Rat Hypothalamus. Neuropsychopharmacology 1999;21:352-367.
5. Clemett DA, Kendall DA, Cockett MI, Marsden CA, Fone KCF Pindolol- Insensitive [3H]-5-Hydroxytryptamine Binding in the Rat Hypothalamus; Identity with 5-Hydroxytryptamine7 Receptors. Br J Pharmacol 1999;127:236-242.
6. 7 Receptor Antagonist. Br J Pharmacol 2000;130:539-548.
7. Sleight AJ, Carolo C, Petit N, Zwingelstein C, Bourson A Identification of 5-Hydroxytryptamine7 Receptor Binding Sites in Rat Hypothalamus: Sensitivity to Chronic Antidepressant Treatment. Mol Pharmacol 1995;47:99-103.
8. 7 Receptor Antagonist of Potential Clinical Interest. CNS Drug Rev 2002;8:90-100.
9. 7 Receptor Mediating Smooth Muscle Relaxation in Canine Cerebral Arteries. Br J Pharmacol 1999;127:609 616.
10. 7 Receptor Involved in the Pathogenesis and Prophylactic Treatment of Migraine? Eur J Pharmacol 2002;439:1-11.
11. 7 Receptors Mediate Serotonergic Effects on Light-Sensitive Suprachiasmatic Nucleus Neurons. Brain Res 1997;755:246-254.
12. 7 Receptor Antagonist, Modulates REM Sleep in Rats. Br J Pharmacol 2003;139:705-714.
13. 7 Antagonist: (R)-3-(2-(2-(4-Methylpiperidin-1-yl) ethyl) pyrrolidine-1-sulfonyl) phenol (SB-269970). J Med Chem 2000;43:342-345.
14. 7 Receptor Antagonists. J Med Chem 2001;44:1337-1340.
15. 7 Receptor Agonists and Antagonists. J Med Chem 2004; 47:3927-3930.
16. 7 Receptor Antagonist with Improved in vivo Properties. Bioorg Med Chem. Lett 2002;12:3341-3344.
17. 7 Receptor Antagonists. Bioorg Med Chem Lett 2003;13:1055-1058.
18. 7 Antagonists. Bioorg Med Chem Lett 2004;14:4245-4248.
19. Leopoldo M, Berardi F, Colabufo NA, Contino M, Lacivita E, Niso M, et al. Structure-Affinity Relationship Study on N-(1,2,3,4- tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinea lkylamides, a New Class of 5-Hydroxytryptamine7 Receptor Agents. J Med. Chem 2004;47:6616-6624.
20. 7 Agonists. Bioorg Med Chem Lett 2003;13:269-271.
21. 7 Receptor Ligands. J Med Chem 2003;46:646-649.
22. 7 Receptor. Bioorg Med Chem Lett 2005;15:747-750.
23. Koyama M, Kikuchi Ch, Ushiroda O, Ando T, Nagaso H, Fuji K, et al. Preparation of Tetrahydrobenzindole Derivatives for the Treatment or Prevention of Mental Diseases. Chem Abstr 1997;128:114961.
24. 7 Receptor. J Med Chem 1999;42:533-535.
25. Kikuchi Ch, Ando T, Watanabe T, Nagaso H, Okuno M, Hiranuma T, et al. 2a-[4- (Tetra-hydropyridoindol-2-yl)butyl]tetrahydrobenzindole Derivatives: New Selective Antagonists of the 5-Hydroxytryptamine7 Receptor. J Med Chem 2002;45:2197-2206.
26. 7 Receptor. Bioorg Med Chem Lett 2002;12:2549-2552.
27. 7 Antagonists With Increased in vitro Metabolic Stability. Bioog Med Chem. Lett 2003;13:61-64.
28. 7 Receptor Antagonists. J Med Chem 2008;51:2522-2532.
29. Fujita T, Ban T. Structure-Activity Relation. 3. Structure-Activity Study of Phenethylamines as Substrates of Biosynthetic Enzymes of Sympathetic Transmitters. J Med Chem 1971;14:148-152.
30. Hansch C Leo AJ. Substituents Constants for Correlation Analysis in Chemistry and Biology. John Wiley (New York); 1979.
31. So S-S, Karplus M Three-Dimensional Quantitative Structure-Activity Relationship from Molecular Similarity Matrices and Genetic Neural Networks. 1. Method and Validation. J Med Chem 1997;40:4347-4359.
32. Wold S Validations of QSARs. Quant Struct-Act Relat 1991;10;191-193.
33. Akaike H Information Theory and an Extension of the Minimum Likelihood Principle. In: Petrov BN, Csaki F, editors. Second International Symposium on Information Theory. Budapest: Akademiai Kiado; 1973. p. 267-281.
34. Akaike H A New Look at the Statistical Identification Model. IEEE Trans Autom Control 1974;AC-19:716-723.
35. Kubinyi H Variable Selection in QSAR Studies. I. An Evolutionary Algorithm. Quant Struct-Act Relat 1994;13:285-294.
36. Kubinyi H Variable Selection in QSAR Studies. II. A Highly Efficient Combination of Systematic Search and Evolution. Quant Struct-Act Relat 1994;13:393-401.
37. Friedman J In: Technical Report No. 102. Laboratory for Computational Statistics. Stanford University, Stanford; 1990.
38. Lipnick RL Outliers: Their Origin and Use in the Classification of Molecular Mechanics of Toxicity. Sci Total Environ 1991;109:131-153.